Governor Larry Hogan visited several mass COVID-19 vaccination sites in Maryland Monday.
Hogan also stopped by Emergent BioSolutions in Southeast Baltimore. That’s where doses of the Johnson & Johnson COVID-19 vaccine is being made.
The company applied for emergency use authorization of its vaccine last week.
The vaccine is not as effective as the Pfizer and Moderna ones, but it only requires one shot and does not need special freezer storage.
“This is a real exciting development,” said Hogan. “The fact that we’re very close to emergency use authorizations for a couple of additional vaccine candidates that we may be manufacturing right here in the state of Maryland that’s very hopeful.”
The FDA’s Vaccines and Related Biological Products Advisory Committee will meet on February 26 to discuss Johnson & Johnson’s request.
Once approved, Emergent BioSolutions will start to mass-produce the vaccine. The U.S. has placed an order for 100 million doses. Johnson & Johnson says it can deliver that amount by June.